Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.32552
Abstract: Histone demethylases are promising therapeutic targets as they play fundamental roles for survival of Mixed lineage leukemia rearranged acute leukemia (MLLr AL). Here we focused on the catalytic Jumonji domain of histone H3 lysine 9… read more here.
Keywords: jdi; leukemia cells; jdi jdi; molecular modulators ... See more keywords